Technical Analysis for AWH - Aspira Women's Health Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Outside Day | Range Expansion | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
180 Bearish Setup | Bearish Swing Setup | 1.39% | |
NR7 | Range Contraction | 1.39% | |
Narrow Range Bar | Range Contraction | 1.39% | |
Inside Day | Range Contraction | 1.39% | |
Wide Bands | Range Expansion | 1.39% | |
Wide Bands | Range Expansion | -0.82% | |
Oversold Stochastic | Weakness | -0.82% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -0.54% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | about 16 hours ago |
10 DMA Resistance | about 17 hours ago |
60 Minute Opening Range Breakout | about 19 hours ago |
Rose Above Previous Day's High | about 19 hours ago |
Rose Above 10 DMA | about 19 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/20/2024
Aspira Women’s Health Inc. (formerly known as Vermillion, Inc. Nasdaq: VRML) is transforming women’s health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1®plus combines our FDA-cleared products OVA1® and OVERA® to detect the risk of ovarian malignancy in women with adnexal masses. ASPiRA GenetiXSM testing offers both targeted and a more comprehensive genetic testing options with a gynecologic focus. Our focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Clinical Medicine Oncology Healthcare Providers FDA Ovarian Cancer Genetic Testing Gynaecology Patient Management Analytical Solutions Gynaecological Cancer
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Clinical Medicine Oncology Healthcare Providers FDA Ovarian Cancer Genetic Testing Gynaecology Patient Management Analytical Solutions Gynaecological Cancer
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 7.755 |
52 Week Low | 2.3087 |
Average Volume | 32,680 |
200-Day Moving Average | 3.97 |
50-Day Moving Average | 4.46 |
20-Day Moving Average | 3.97 |
10-Day Moving Average | 3.71 |
Average True Range | 0.33 |
RSI (14) | 36.31 |
ADX | 28.65 |
+DI | 10.77 |
-DI | 20.54 |
Chandelier Exit (Long, 3 ATRs) | 4.00 |
Chandelier Exit (Short, 3 ATRs) | 4.40 |
Upper Bollinger Bands | 4.71 |
Lower Bollinger Band | 3.24 |
Percent B (%b) | 0.28 |
BandWidth | 36.86 |
MACD Line | -0.24 |
MACD Signal Line | -0.22 |
MACD Histogram | -0.02 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 4.06 | ||||
Resistance 3 (R3) | 4.06 | 3.94 | 3.99 | ||
Resistance 2 (R2) | 3.94 | 3.83 | 3.93 | 3.96 | |
Resistance 1 (R1) | 3.79 | 3.77 | 3.79 | 3.79 | 3.94 |
Pivot Point | 3.67 | 3.67 | 3.66 | 3.66 | 3.67 |
Support 1 (S1) | 3.52 | 3.56 | 3.52 | 3.52 | 3.36 |
Support 2 (S2) | 3.40 | 3.50 | 3.39 | 3.34 | |
Support 3 (S3) | 3.25 | 3.40 | 3.31 | ||
Support 4 (S4) | 3.25 |